EMAIL THIS PAGE TO A FRIEND

Journal of cellular and molecular medicine

Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells.


PMID 26147006

Abstract

The purpose of this study was to determine the correlation between over-expression of the neuropilin 1 (NRP1) gene and growth, survival, and radio-sensitivity of non-small cell lung carcinoma (NSCLC) cells. 3-[4,5-dimethylthylthiazol-2-yl]-2,5 diphenyltetrazolium broide (MTT) and colony assays were then performed to determine the effect of NRP1 inhibition on the in vitro growth of NSCLC cells. The Annexin V-Fluorescein Isothiocyanate (FITC) apoptosis detection assay was performed to analyse the effect of NRP1 enhancement on apoptosis of NSCLC cells. Transwell invasion and migration assays were employed to examine the metastatic ability of A549 cells post X-ray irradiation. In addition, Western blot assays were carried out to detect the protein level of VEGFR2, PI3K and NF-κB. Finally, to examine the effect of shNRP1 on proliferation and radio-sensitivity in vivo, a subcutaneous tumour formation assay in nude mice was performed. Microvessel density in tumour tissues was assessed by immunohistochemistry. The stable transfected cell line (shNRP1-A549) showed a significant reduction in colony-forming ability and proliferation not only in vitro, but also in vivo. Moreover, shRNA-mediated NRP1 inhibition also significantly enhanced the radio-sensitivity of NSCLC cells both in vitro and in vivo. The over-expression of NRP1 was correlated with growth, survival and radio-resistance of NSCLC cells via the VEGF-PI3K- NF-κB pathway, and NRP1 may be a molecular therapeutic target for gene therapy or radio-sensitization of NSCLC.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1406175
Anti-NELL1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA051535
Anti-NELL1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410833
Anti-NELL1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA030278
Anti-NRP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1411572
Anti-NRP1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
GW21071 Anti-PI3K antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2701957
Anti-PIK3CA antibody produced in rabbit
HPA001216
Anti-PIK3R1 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106248
Anti-PIK3R1 antibody produced in rabbit, affinity isolated antibody
EHU095021 MISSION® esiRNA, esiRNA human NELL1 (esiRNA1)
EHU134551 MISSION® esiRNA, esiRNA human NRP1 (esiRNA1)
WH0004745M1
Monoclonal Anti-NELL1 antibody produced in mouse, clone 6A8, purified immunoglobulin, buffered aqueous solution
SAB1404116
Monoclonal Anti-NELL1 antibody produced in mouse, clone 3F1, purified immunoglobulin, buffered aqueous solution
N3287 Monoclonal Anti-Neuropilin-1 antibody produced in mouse, clone 130603, purified immunoglobulin, lyophilized powder
WH0008829M5
Monoclonal Anti-NRP1 antibody produced in mouse, clone 1B3, purified immunoglobulin, buffered aqueous solution
SAB1404632 Monoclonal Anti-NRP1, (C-terminal) antibody produced in mouse, clone 3G6-2C5, ascites fluid
WH0005290M1 Monoclonal Anti-PIK3CA antibody produced in mouse, clone 3G3, purified immunoglobulin, buffered aqueous solution
SAB5300225
Monoclonal Anti-PIK3CA antibody produced in mouse, clone 4F3, purified immunoglobulin, buffered aqueous solution
WH0005295M1
Monoclonal Anti-PIK3R1 antibody produced in mouse, clone 3A10, purified immunoglobulin, buffered aqueous solution
SAB1404206
Monoclonal Anti-PIK3R1 antibody produced in mouse, clone 1C10, purified immunoglobulin, buffered aqueous solution
SRP3126 NP-1 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested